These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1330941)

  • 1. Specific and high affinity binding of perindoprilat, but not of perindopril to blood ACE.
    Bree F; Nguyen P; Urien S; Resplandy G; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):325-30. PubMed ID: 1330941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single dose pharmacokinetics of perindopril and its metabolites in hypertensive patients with various degrees of renal insufficiency.
    Verpooten GA; Genissel PM; Thomas JR; De Broe ME
    Br J Clin Pharmacol; 1991 Aug; 32(2):187-92. PubMed ID: 1657092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First LC-MS/MS electrospray ionization validated method for the quantification of perindopril and its metabolite perindoprilat in human plasma and its application to bioequivalence study.
    Jain DS; Subbaiah G; Sanyal M; Pande UC; Shrivastav P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 837(1-2):92-100. PubMed ID: 16709467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination kinetics of quinaprilat and perindoprilat in hypertensive patients with renal failure on haemodialysis.
    Yamada S; Muraoka I; Kato K; Hiromi Y; Takasu R; Seno H; Kawahara H; Nabeshima T
    Biol Pharm Bull; 2003 Jun; 26(6):872-5. PubMed ID: 12808303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of perindopril and its effects on serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure.
    Sennesael J; Ali A; Sweny P; Vandenburg M; Slovic D; Dratwa M; Resplandy G; Genissel P; Desche P
    Br J Clin Pharmacol; 1992 Jan; 33(1):93-9. PubMed ID: 1311597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of perindoprilat in normal volunteers and patients: influence of age and disease state.
    Parker E; Aarons L; Rowland M; Resplandy G
    Eur J Pharm Sci; 2005 Sep; 26(1):104-13. PubMed ID: 15982858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.
    Zini R; Morin D; Salvadori C; Tillement JP
    Br J Clin Pharmacol; 1990 Jan; 29(1):9-18. PubMed ID: 2297464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the pharmacokinetics and pharmacodynamics of oral doses of perindopril in normotensive Chinese and Caucasian volunteers.
    Anderson PJ; Critchley JA; Tomlinson B; Resplandy G
    Br J Clin Pharmacol; 1995 Apr; 39(4):361-8. PubMed ID: 7640141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of food on the pharmacokinetics of perindopril and the time course of angiotensin-converting enzyme inhibition in serum.
    Lecocq B; Funck-Brentano C; Lecocq V; Ferry A; Gardin ME; Devissaguet M; Jaillon P
    Clin Pharmacol Ther; 1990 Mar; 47(3):397-402. PubMed ID: 2311339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics and pharmacodynamics of perindopril in patients with hepatic cirrhosis.
    Tsai HH; Lees KR; Howden CW; Reid JL
    Br J Clin Pharmacol; 1989 Jul; 28(1):53-9. PubMed ID: 2550045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease.
    Zhuo JL; Froomes P; Casley D; Liu JJ; Murone C; Chai SY; Buxton B; Mendelsohn FA
    Circulation; 1997 Jul; 96(1):174-82. PubMed ID: 9236432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro binding study of gemfibrozil to human serum proteins and erythrocytes: interactions with other drugs.
    Hamberger C; Barre J; Zini R; Taiclet A; Houin G; Tillement JP
    Int J Clin Pharmacol Res; 1986; 6(6):441-9. PubMed ID: 3468088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of 5-methoxypsoralen to blood fractions. Influence of albumin and free fatty acids: an in vitro study.
    Muret P; Makki S; Urien S; Agache P; Bechtel P; Tillement JP
    Skin Pharmacol; 1993; 6(1):45-51. PubMed ID: 7683892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of minaprine to human serum proteins and erythrocytes.
    Barré J; Houin G; Jeanniot JP; Coirre C; Tillement JP
    Int J Clin Pharmacol Res; 1986; 6(1):1-9. PubMed ID: 3957500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics of perindopril in patients with liver cirrhosis.
    Thiollet M; Funck-Brentano C; Grangé JD; Midavaine M; Resplandy G; Jaillon P
    Br J Clin Pharmacol; 1992 Mar; 33(3):326-8. PubMed ID: 1576057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood binding of selezen (imidazole salicylate) in man.
    Zini R; Morin D; Acuto GC; Bianchini C; de Santis F; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1991 Jun; 29(6):242-9. PubMed ID: 1869346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of perindopril on angiotensin converting enzyme in tissues of the rat.
    Jackson B; Cubela RB; Johnston CI
    J Hypertens Suppl; 1988 Dec; 6(3):S51-4. PubMed ID: 2852236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR identification of endogenous metabolites interacting with fatted and non-fatted human serum albumin in blood plasma: Fatty acids influence the HSA-metabolite interaction.
    Jupin M; Michiels PJ; Girard FC; Spraul M; Wijmenga SS
    J Magn Reson; 2013 Mar; 228():81-94. PubMed ID: 23357430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modeling of the relation between plasma concentration of the active metabolite of perindopril and inhibition of the activity of plasma converting enzyme in healthy volunteers].
    Bellissant E; Chau NP; Thuillez C; Giudicelli JF
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1285-9. PubMed ID: 2175584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with perindopril in normal volunteers.
    Waeber B; Nussberger J; Perret L; Santoni JP; Brunner HR
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():35-41. PubMed ID: 2549899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.